Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Previous years symbols : GOVX save search
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 4.21%
H: 1.01%
C: 1.01%
cm04 covid-19 vaccine congress world
GeoVax to Present at the 36th Annual Roth Conference
Published: 2024-03-12 (Crawled : 13:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 0.0%
H: 4.21%
C: -3.27%
conference
GeoVax to Present at the 2024 BIO CEO & Investor Conference
Published: 2024-02-19 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
| Email alert
Add to watchlist
ceo conference
GeoVax Announces Multiple Patent Issuances and Allowances
Published: 2024-02-13 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 2.65%
H: 0.0%
C: -6.27%
patent
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
Published: 2024-02-06 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 2.77%
H: 2.69%
C: 1.92%
cm04 covid-19 vaccine universal geo-cm04s1 positive trial
GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
Published: 2024-01-29 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 5.82%
H: 0.0%
C: -13.3%
nasdaq
GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 0.11%
H: 4.05%
C: 0.0%
medical
GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
Published: 2024-01-04 (Crawled : 00:00) - biospace.com/
GOVX | $1.52 480
|
Health Technology
|
| O: 4.19%
H: 0.0%
C: -6.41%
gedeptin cancer trial advanced
GeoVax Announces Issuance of Malaria Vaccine Patent
Published: 2024-01-03 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 2.7%
H: 5.26%
C: -1.5%
patent vaccine malaria
Corporate Transparency Act Applied to M&A | Perkins Coie – JDSupra – JD Supra
Published: 2024-01-02 (Crawled : 22:00) - spacfeed.com
GOVX | $1.52 480
|
Health Technology
|
| O: 2.7%
H: 5.26%
C: -1.5%
Biden wants federal agencies to cut back on single-use plastics – Plastics News
Published: 2024-01-02 (Crawled : 22:00) - spacfeed.com
MSSV | $0.036 85
|
Administrative and Support and ...
|
| O: 43.84%
H: 2.86%
C: 2.86%
GOVX | $1.52 480
|
Health Technology
|
| O: 2.7%
H: 5.26%
C: -1.5%
back
Civitas Resources Closes Acquisition of Vencer Energy | Business … – Valdosta Daily Times
Published: 2024-01-02 (Crawled : 22:00) - spacfeed.com
MSSV | $0.036 85
|
Administrative and Support and ...
|
| O: 43.84%
H: 2.86%
C: 2.86%
GOVX | $1.52 480
|
Health Technology
|
| O: 2.7%
H: 5.26%
C: -1.5%
energy business acquisition
Iron Horse Acquisitions Announces $69 Million IPO Close – Digital Music News
Published: 2024-01-02 (Crawled : 22:00) - spacfeed.com
GOVX | $1.52 480
|
Health Technology
|
| O: 2.7%
H: 5.26%
C: -1.5%
acquisitions million
Novanta completes acquisition of Motion Solutions – Financial Post
Published: 2024-01-02 (Crawled : 22:00) - spacfeed.com
GOVX | $1.52 480
|
Health Technology
|
| O: 2.7%
H: 5.26%
C: -1.5%
acquisition solutions financial
GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024
Published: 2023-12-27 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 2.74%
H: 9.33%
C: -0.53%
biotech week
GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox
Published: 2023-12-19 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 5.76%
H: 0.95%
C: -2.59%
covid-19 license smallpox
GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress
Published: 2023-11-28 (Crawled : 14:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: -2.52%
H: 14.22%
C: 5.39%
covid-19 vaccine congress world
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: -3.75%
H: 2.93%
C: 2.17%
business update financial results
GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine
Published: 2023-10-30 (Crawled : 13:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: 0.0%
H: 2.02%
C: -1.42%
covid-19 vaccine expansion trial phase 2
GeoVax to Participate in Upcoming November Investor and Industry Events
Published: 2023-10-25 (Crawled : 13:00) - globenewswire.com
GOVX | $1.52 480
|
Health Technology
|
| O: -0.2%
H: 0.1%
C: -4.02%
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.